Sometimes, we take sleep for granted. But getting a good night’s sleep can be key to maintaining a healthy metabolism and preventing diabetes and obesity.

High blood sugar readings have been tied to a greater risk for heart disease. While these blood sugar readings may signal risk of pre-diabetes or diabetes, they may not be a sign that heart disease waits ahead.

Combination therapy using two different types of diabetes medication can effectively control blood sugar. New research confirms that adding vildagliptin to metformin can be a beneficial mix.

Research has shown that popular cholesterol-lowering medications may increase the chances of developing type 2 diabetes. Weight control, however, may keep the diabetes away.

Diabetes and obesity are problematic on their own, but could they also affect how the body responds to treatments for other conditions, like cancer? New studies suggest this is the case.

Among the complications that can occur during a pregnancy is gestational diabetes. Though gestational diabetes usually goes away after pregnancy, its risks may not always.

Widely given to patients with type 2 diabetes, metformin has been linked to reducing the risk for many types of cancers. The medication, however, may not be effective against one certain cancer.

Saxagliptin is a popular diabetes medication that helps lower blood sugar levels. Because research has shown that it may worsen heart failure, the FDA plans to review data on this medication.

About eight in 10 people with type 2 diabetes are overweight or obese. While weight is related to the condition, putting on pounds over a few years may not signal increased risk.

Diabetes greatly increases the possibility of having a heart attack or stroke. Early detection and treatment, however, can prevent further progression of the disease.